Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors

Figure 1

The levels of serum Cys-C in elder BUT patients (more than 60 years) were higher than that in younger patients (). The levels of serum Cys-C in male BUT patients were higher than in female patients (). The mean Cys-C level of patients with PFL < 2.88 g/L, which was significantly lower than that of patients with PFL ≥ 2.88 g/L (). P: parametric Student’s -test.